The top 10 DPN-related metabolic pathways, obtained by KEGG enrichment analysis of intersection targets, included insulin resistance, type II diabetes, and insulin signaling pathways, indicating that one of the main mechanisms of SL in the treatment of DPN is the regulation of blood glucose. The gene discussed is INS; the disease is Insulin resistance.